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Abstract [278 words] 
Objective 
To explore parents’ perceptions and experience of being approached for enrolment 
of their preterm infant in more than one trial or study. 
Design 
A qualitative study involving 17 in-depth semi-structured interviews, with parents who 
had been approached for multiple studies, and subsequently consented for their 
infant(s) to join at least one. Parents who declined all studies were not approached. 
Setting and participants 
Parents of preterm infants receiving care at one of 3 neonatal intensive care units in 
the north of England. 
Findings 
Most parents did not view concurrent participation in multiple trials or studies as a 
significant issue within the wider context of their infant’s care. Most parents did not 
feel pressured into enrolling their infant into more than one study, but some 
suggested that participation in several provided justification for the subsequent 
refusal to join others, articulating feeling of guilt at saying ‘no’, and others appeared 
fatigued by multiple approaches. Parents focused upon the perceived risks and 
benefits of each individual study and, whilst acknowledging that making a fully 
informed decision was not possible, largely agreed due to their belief in the benefits 
of research, trust in the health professionals caring for their baby and a range of 
complex personal motivations.  
Conclusions 
Parents valued the autonomy to make decisions about participation and felt, with 
hindsight, that their decisions were right. Research teams could be more aware of 
parental feelings of guilt or gratitude that may motivate them to give consent. 
Similarly, the capacity of parents to fully remember details of multiple studies when 
they are stressed, and their infant is sick, should be taken into consideration and 
continued efforts made to ensure ongoing consent to participation. 
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Background 
Neonatal practice requires a strong evidence base but randomised controlled trials 
(RCTs) involving enrolment shortly after birth when parents may be anxious are 
challenging. Research teams must balance this additional stress against the need to 
achieve successful recruitment1, whilst ensuring decisions are made in the infant’s 
best interests. Parents want to be involved in these decisions whilst still seeking 
guidance from health professionals2. Most studies suggest parents feel they made 
well-informed decisions although achieving fully informed consent can be 
challenging3–5. Parents consider anticipated level of risk and benefit when deciding 
whether to join a study6,7, but in many Neonatal Intensive Care Units (NICUs) it is 
common for parents to be approached for more than one study. Approach and 
enrolment to more than one study may raise ethical and scientific issues in the NICU8 
although these are seen in other settings9. Working with parents as part of patient 
public involvement (PPI) when planning, conducting and analysing studies is 
appropriately considered essential. Where co-enrolment does not compromise 
scientific integrity it might be considered unfair to deny parents a choice, and may 
also improve generalisability of study findings8. Our aim here was to explore the 
perceptions and experiences of parents who were approached to take part in more 
than one research study. 
Methods 
This study was focused on parents’ experiences whose infants were invited to join 
either of two clinical trials funded by the National Institute for Health Research. These 
RCTs were: 1) the Speed of Increases in Feeds Trial – an unmasked RCT comparing 
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two different daily increments in milk feed volumes, and 2) the Enteral Lactoferrin in 
Neonates trial - a blinded RCT trial of supplemental enteral lactoferrin10,11. Further 
details of other trials and studies that were active at this time are provided in the 
supplementary table. After PPI discussion we only requested ethics permission to 
interview parents whose infant/s had joined at least one trial or study, even if they 
chose to decline others. Therefore, we did not approach parents who had declined 
participation in all trials or studies they were offered. Parents were recruited when 
their infant was medically stable and prior to hospital discharge. For further details on 
participants, procedures and data analysis please see supplementary materials. 
Guided by PPI, we developed a topic guide that was iterative and flexible, allowing 
parents the opportunity to define issues and experiences14 and we estimated we 
would need 15-20 interviews until we reached thematic saturation15. Interviews were 
conducted by a single trained qualitative researcher with experience of interviewing 
parents of sick newborn infants, but who was not a health professional. 
We used a thematic approach to data analysis4 whereby two research team 
members reviewed transcripts to ensure standardisation of thematic coding. We then 
extracted significant themes and subthemes for further discussion and agreement. 
The study was approved by the Office for Research Ethics Committees Northern 
Ireland: ref 15/NI/0021, 02/02/2015 and reporting follows SRQR guidelines.16 
Findings 
We carried out seventeen semi-structured qualitative interviews between 01/04/15 
and 28/02/16 with eight parents of twins, eight parents of singletons, and one set of 
triplets. Seven interviews were with both parents, nine were with the mother alone, 
and in one interview with a mother the infant grandparent was also present. Data 
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analysis identified four overarching themes regarding parents’ decisions when they 
considered whether to join more than one study. 
Theme 1. ‘Just another little thing’ 
Most parents did not consider joining more than one study as a major issue in the 
context of their infant’s daily medical care (see Box 1 for additional quotes).  
“I, Yeah, it didn’t bother me being asked. I think because I had been bombarded with so 
much stuff that day that it was just kind of ‘it’s another little thing’” 
The actual number of studies (range 1-5) was not raised as being important and 
being asked about several studies shortly after NICU admission was not seen as a 
problem. Most parents held a strong belief in the benefits of research, trusted health 
professionals that joining a study would not compromise their infants’ care, and most 
viewed joining more than one study positively. Some parents of sick infants where 
survival was uncertain perceived enrolment as a ‘gift’ or a way of making their 
infant’s potentially short life matter. Many parents appeared to forget about studies 
once they were underway, but a small number raised concerns about whether 
running two trial interventions together might cause problems. 
…‘I thought that em… the RCT 2 one was just one step too far for me personally. I just felt 
like if they are messing around with her feeding, the amount of feed and then they are putting 
something new in as well then I thought, I don’t want that.’ 
Theme 2. Information Gathering 
Parents considered the specifics of each study and tried to get as much information 
as they could in order to make their decision. Parents preferred succinct parent 
information sheets (PIS) that gave information in a clear,’ jargon-free’ fashion and 
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placed importance on the opportunity to talk through any concerns with a health 
professional.  
‘…coz the leaflets were very well set out and quite sort of succinct which is quite important 
when you are in such a distractible kind of mood constantly’ 
Parents didn’t generally seek advice from other parents on the NICU, but some 
looked for ‘stickers’ on infant’s incubators that signified trial participation. Conversely, 
others didn’t read the PIS in detail but chose to take part for a range of reasons 
including: feeling a moral obligation to take part for the benefit of future babies; the 
perception that their baby was benefitting from previous research; or parents desire 
to repay the clinical teams for their baby’s care (see box 2). 
‘… in my logical mind I knew that I should probably take part in this kind of thing because if 
people hadn’t done that 40 or 50 years ago then my babies wouldn’t be here now. I thought, 
“It is my duty to think about the future.” 
Parents said they were given all the information they needed but some said they 
sometimes felt too upset or unwell to fully take in all the information about the study 
especially if the approach came soon after delivery. Some parents said they couldn’t 
remember what the studies were called or understand what the study involved, but 
none said they regretted their decisions.  
‘I think we did three but - this sounds really awful - I’m not sure of the second one…” 
Although parents considered the PIS important, they considered the approach of the 
research team member as very influential in their decision, and valued a friendly and 
informal, but confident manner. Most did not say they felt pressured into joining and 
appreciated being given as much time as they needed. Whilst many could not 
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remember the names of studies or what they involved, they clearly remembered the 
research team member or health professional who first introduced the study. 
Theme 3. Making decisions - ‘weighing up the pros and cons’ 
Parents decided whether to join a study based on the perceived risks of individual 
studies rather than the number of studies they were asked to consider. (see box 3) 
Parents considered the wellbeing of their infant, how medically invasive the trial 
appeared to be, how important they thought the study was and several personal 
factors. 
“….we realised, research doesn’t know so we don’t know so we might as well, we can’t make 
an informed decision about whether one is better than the other so we might as well put her 
in the trial.” 
Most acknowledged the challenges of making a fully informed decision and in the 
uncertainty, drew upon more personal, non-medical risk assessments. These 
included: wondering what decision the ‘baby’ might have made; considering the 
study might help their infant; welcoming ‘another pair of eyes’ to look at the care their 
baby was receiving; a sense of purpose which helped counteract feelings of 
helplessness; a way of getting their infant home sooner; and, a debt of gratitude. 
Theme 4. Saying ‘no’ 
Whilst parents were happy being approached to join more than one study, they did 
not agree to join them all. Some said they felt guilty when declining, often because 
they felt they owed it to future generations to take part. Many could not remember 
how many studies their infant joined but taking part in more than one provided 
justification to refuse others as it gave the impression they had ‘done their bit’. 
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Parents who declined were divided as to whether they felt they needed to justify their 
decision. 
‘… it felt almost like we’d done our bit, if that make sense.’ 
Parents gave several reasons for declining to join, but some said the timing was 
important, for example if they were approached shortly before hospital discharge 
they were keen not to jeopardise this and saw joining another study at that stage as 
a potential threat to their infant leaving hospital on time. A small minority of parents 
who were asked to join a study when their infant was sick felt this was inappropriate 
and that the research team had not read the hospital notes properly. Several parents 
highlighted that it takes confidence to say ‘no’ to a health professional who might be 
caring for their infant. Some were relieved to be supported by nurses in their decision 
to decline, whilst others felt their decision was not initially accepted by the research 
team, leaving them feeling pressurized and guilty (see Box 4). 
“And he kept coming back to me. You know? That’s why I felt guilty. I felt like I was, kind of, 
letting him down a little bit’.” 
Discussion 
Approaching parents for permission to enrol their infant into more than one study is 
an important challenge on many NICUs8, and whilst some data suggests this may 
not be problematic for many, there are few in-depth qualitative studies6,17–19. Our 
study provides an in-depth analysis of parental experiences and motivations and 
supports the idea that joining more than one study is not necessarily problematic. 
Many suggested complex personal reasons which helped them see research 
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positively, whilst others provided important insights into their decisions including 
feelings of guilt or obligation. 
Our study has several strengths. The semi-structured nature of the interviews 
allowed parents to consider their experiences, typically several weeks after they 
were approached. Parents articulated issues in their own words that they felt 
important to an impartial researcher who was not a health professional and acted as 
a ‘naive observer’. Furthermore, we used methods that reassured parents of 
complete anonymity.  
Nevertheless, our findings require careful interpretation. The design and types of 
studies may limit generalisability to other settings such as the specifics of the 
hospitals, the timing of approach, the interventional nature of the studies, the 
experience of having an infant who joined a study and survived, and the attitudes, 
behaviours and beliefs of the clinical and research teams involved. Although we 
used a form of purposive sampling, we did not record socio-demographic information 
about our parents and were not able to explore how those or other factors such as 
ethnicity or religion impact upon their experiences and decisions. Around half of our 
parents had twin or triplet pregnancies, but we did not explore how this affects 
decisions, although data suggest parents have important views on co-
randomisation20. We did not seek ethics permissions to speak to parents who 
declined to join any study offered, or where the infant subsequently died21. 
 
Our study suggests parents make separate decisions about each study in turn, 
judging each by its own perceived ‘pros and cons’,6,22 and emphasise that parents 
want to make final decisions about enrolment, in contrast with data that suggested 
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some parents expected health professionals to make the decision2,23. Whilst most 
felt they made decisions they didn’t later regret, some said that they had not initally 
understood trial information properly and that subsequent trial procedures came as a 
surprise. This highlights the challenges of gaining fully informed consent, the 
importance of continued involvement of the research team in explaining ongoing 
procedures, and the rights of parents to withdraw or to decline specific 
procedures2,5,6,19,23. Importantly, most parents acknowledged that despite feeling 
stressed, they were still happy with their decisions, frequently citing their faith in 
health professionals to protect their infant. Many suggested they would have liked 
information about the studies before the baby was born, and whilst many 
acknowledged there were time pressures on decision making, they did not feel they 
made decisions inadvisably either at the time or on reflection. 
Conclusions  
 
This in-depth study emphasises the need for researchers to be aware of several 
factors when speaking to parents especially in the context of co-enrolment. Few 
parents expressed regrets, but some decisions may have been motivated by guilt, a 
debt of gratitude or lack of confidence to refuse. Parents recognised the challenges 
of gaining fully informed consent, but most felt their decisions were ‘good enough’ 
given the circumstances. A better understanding of this may help health 
professionals to support parents better. 
Data from this study could be used in Good Clinical Practice training, ongoing 
education for ‘front-line’ researchers and others involved in designing or supporting 
research. This study highlights the importance of involving PPI representatives when 
developing a PIS and with all aspects of research design and suggests that changing 
the PIS may be useful if co-enrolment is likely. Our study highlights the 
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‘overwhelming’ nature of having a sick infant, the additional challenge of being asked 
to join multiple research studies, and the need for all researchers to consider how 
best to improve parent satisfaction and understanding of the need for research.  
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“What is already known on this topic”  
1. Parents of newborn infants may be asked to consider joining more than one study 
or trial: this is important for timely completion of studies and a reflection of real-
world practices. 
2. Researchers have concerns about asking parents to take part in more than one 
study for ethical and scientific reasons and due to the potential for overburdening 
families at a stressful time. 
3. There are mixed views amongst health care professionals and research ethics 
committees about what is felt to be appropriate in the context of sick newborn 
infants. 
 
“What this study adds”  
1. Parents did not usually report regretting their decisions, but some reported 
feelings of guilt or anxiety due to declining or agreeing to study participation. 
2. Participant information leaflets may benefit from being written differently where 
multiple study participation is anticipated, and these are best co-designed with 
parents and the public  
3.   Research teams should be aware of the potential for overwhelming families 
and the need to actively provide ongoing opportunities to discuss continued 
participation in research studies. 
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